GLP-1

The Next Wave of Weight Loss Science May Come From a Peptide Inside Your Body That Mimics Ozempic

AI found a natural peptide in your body that mimics Ozempic and could shape weight loss science

Comments
TOP STORIES

GLP-1 alternatives are getting fresh attention after Stanford researchers identified a naturally occurring peptide called BRP that suppressed appetite in animals without the nausea, constipation and muscle loss that have driven so many people off Ozempic. Here’s what the science actually shows and what’s worth knowing before you get too excited.

What is BRP and how does it work?

BRP is a 12-amino-acid peptide your body already makes naturally. A March 2025 study in Nature led by Stanford Medicine found it reduced food intake by up to 50% in mice and minipigs within an hour of a single injection. Stanford scientists found BRP using an AI tool called Peptide Predictor that scanned more than 2,600 human peptide fragments to find ones that might act as hormones.

Unlike semaglutide, the active ingredient in Ozempic, BRP acts specifically in the hypothalamus, the brain region that controls appetite and metabolism, rather than hitting receptors across the brain, gut, pancreas and other tissues. The study was funded by the National Institutes of Health.

Why does where it acts in the body matter?

That targeted action is exactly why researchers are excited. Ozempic and similar drugs bind to receptors throughout the body, which is why side effects show up in so many different ways. A RAND Corporation survey of 8,793 U.S. adults released in August 2025 found roughly half of all GLP-1 users experienced nausea and about one-third experienced diarrhea.

A University of Pennsylvania team scanned 400,000 Reddit posts from about 70,000 GLP-1 users and published findings in Nature Health in April 2026 showing 44% reported at least one side effect. Notably, reproductive symptoms including menstrual irregularities appeared to be underreported, which matters because GLP-1 prescribing has grown fastest among women aged 30 to 49.

The Reddit sample skews younger and male, so there are limits to what it shows, but clinicians say the pattern tracks what they hear in practice. In animal tests, BRP triggered none of those complaints.

Does BRP have side effects in humans?

Nobody knows yet, because BRP has not been tested in people at all. The “no side effects” finding is based entirely on animal studies. Until BRP reaches human clinical trials, that question simply can’t be answered.

When will BRP be available?

Not for a while. BRP has not been tested in humans, has not been reviewed by the FDA and is not available anywhere. Stanford says human trials are expected soon, but even in the best case scenario new drugs take several years to move through safety and efficacy testing before approval.

Two things worth knowing before drawing any conclusions. Lead author Katrin Svensson co-founded Merrifield Therapeutics, the company planning to commercialize BRP, and both she and co-author Laetitia Coassolo hold patents related to BRP peptides. That doesn’t invalidate the research, but it’s context worth having.

Also, “natural” here means the body already produces this peptide, not that you can buy it anywhere. There’s no supplement version, nothing to order online and no food that contains it.

Is there anything available now that works similarly?

For now, the only approaches with real clinical backing for metabolic health are the GLP-1 drugs themselves and lifestyle strategies like changing what and when you eat. If you’re on a GLP-1 drug and struggling with side effects, that’s a conversation worth having with your doctor sooner rather than later. And understanding how eating patterns like intermittent fasting fit into that picture is worth exploring while BRP works its way through development.

Conversation

All comments are subject to our Community Guidelines. Woman's World does not endorse the opinions and views shared by our readers in our comment sections. Our comments section is a place where readers can engage in healthy, productive, lively, and respectful discussions. Offensive language, hate speech, personal attacks, and/or defamatory statements are not permitted. Advertising or spam is also prohibited.

More Stories

Use left and right arrow keys to navigate between menu items. Use right arrow key to move into submenus. Use escape to exit the menu. Use up and down arrow keys to explore. Use left arrow key to move back to the parent list.

Already have an account?